{
  "main_header": {
    "sid": 10038954,
    "name": "Asarfi Hospital",
    "stock_name": "Asarfi Hospital",
    "full_name": "Asarfi Hospital Ltd",
    "name_url": "stocks-analysis/asarfi-hospital",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "225.10",
    "chg": -4.2,
    "chgp": "-1.83%",
    "dir": -1,
    "prev_price": "229.30",
    "mcapval": "453.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543943,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE0DN001027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": 17000,
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/asarfi-hospital-10038954-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 89,
    "sid": "10038954",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/asarfi-hospital-10038954"
  },
  "announcements": [
    {
      "caption": "Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.",
      "datetime": "30-May-2026",
      "details": "We wish you to inform you for the year ended March 31 2026 There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each aggregating to Rs.269360000/-issued by the company for the object stated in the offer document.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "30-May-2026",
      "details": "We hereby submit the transcript of the earning conference call held on May 27 2026 wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "27-May-2026",
      "details": "Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated May 21 2026 regarding the schedule of the Institutional Investor/Analyst Meet we hereby inform you that the Company participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing Services (I) Pvt. Ltd. on May 27 2026 through a virtual platform.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News